0.10
Kairos Pharma, LTD.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
4.17
FY25:
5.39
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.86
FY24:
1.60
FY25:
1.15
Total assets
Change from FY23 to FY25
millions USD
FY23:
0.97
FY24:
5.77
FY25:
6.54
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
2.41
FY24:
0.99
FY25:
0.20
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.64
FY24:
0
FY25:
0
(positive)
Change from FY23 to FY25
millions USD
FY23:
−2.08
FY24:
4.78
FY25:
6.34
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
0.97
FY24:
5.77
FY25:
6.54
All amounts in millions USD